Praxis Precision Medicines, Inc. (PRAX) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 12 Buy, 3 Hold, 1 Sell.
The consensus price target is $510.40 (low: $83.00, high: $843.00), representing an upside of 48.5% from the current price $343.60.
Analysts estimate Earnings Per Share (EPS) of $-10.18 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-10.21 vs est $-10.18 (missed -0.3%). 2025: actual $-13.48 vs est $-13.11 (missed -2.9%). Analyst accuracy: 98%.
PRAX Stock — 12-Month Price Forecast
$510.40
▲ +48.54% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Praxis Precision Medicines, Inc., the average price target is $510.40, with a high forecast of $843.00, and a low forecast of $83.00.
The average price target represents a +48.54% change from the last price of $343.60.
Highest Price Target
$843.00
Average Price Target
$510.40
Lowest Price Target
$83.00
PRAX Analyst Ratings
Buy
Based on 16 analysts giving stock ratings to Praxis Precision Medicines, Inc. in the past 3 months
EPS Estimates — PRAX
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$10.21
vs Est –$10.18
▼ 0.3% off
2025
Actual –$13.48
vs Est –$13.11
▼ 2.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — PRAX
17%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.009B
vs Est $0.001B
▲ 82.9% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
